BeOne Medicines (ONC) Share-based Compensation (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Share-based Compensation data on file, last reported at $9.3 million in Q1 2026.

• On a quarterly basis, Share-based Compensation fell 40.86% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $504.5 million, a 3303.91% increase from a year earlier, with the FY2025 full-year figure at $510.9 million, changed N/A from the prior year.
• Share-based Compensation for Q1 2026 stood at $9.3 million, down from $491.7 million in the prior quarter.
• Over the last five years, Share-based Compensation for ONC reached as high as $491.7 million in Q4 2025 and fell as low as -$227.2 million in Q3 2025.
• Historically, Share-based Compensation has averaged $70.1 million across 5 years, with a median of $75.3 million in 2023.
• On a YoY basis, Share-based Compensation climbed as much as 1771.36% in 2025 and fell as far as 10645.96% in 2025.
• Year by year, Share-based Compensation stood at $78.1 million in 2022, then climbed by 18.94% to $92.9 million in 2023, then sank by 131.66% to -$29.4 million in 2024, then jumped by 1771.36% to $491.7 million in 2025, then sank by 98.12% to $9.3 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $9.3 million in Q1 2026, $491.7 million in Q4 2025, and -$227.2 million in Q3 2025.